questionsmedicales.fr
Maladies du système nerveux
Maladies du système nerveux central
Encéphalopathies
Épilepsie
Épilepsies partielles
Épilepsie partielle complexe
Épilepsie partielle complexe : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Épilepsie
Électroencéphalographie
IRM
Électroencéphalographie
Antécédents médicaux
Épilepsie
Symptômes
5
Symptômes
Crises épileptiques
Comportements automatisés
Épilepsie
Prévention
5
Éducation
Premiers secours
Activités physiques
Sécurité
Gestion du stress
Méditation
Traitements
5
Anticonvulsivants
Carbamazépine
Thérapies comportementales
Stimulation cérébrale
Complications
5
Complications
Psychologiques
Prise en charge
Multidisciplinaire
Facteurs de risque
5
Facteurs de risque
Traumatismes crâniens
Maladies neurologiques
Sclérose en plaques
Facteurs environnementaux
Toxines
Stress
Crises épileptiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Épilepsie partielle complexe : Questions médicales les plus fréquentes",
"headline": "Épilepsie partielle complexe : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Épilepsie partielle complexe : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-30",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Épilepsie partielle complexe"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Épilepsies partielles",
"url": "https://questionsmedicales.fr/mesh/D004828",
"about": {
"@type": "MedicalCondition",
"name": "Épilepsies partielles",
"code": {
"@type": "MedicalCode",
"code": "D004828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140.490.360"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Épilepsie partielle complexe",
"alternateName": "Epilepsy, Complex Partial",
"code": {
"@type": "MedicalCode",
"code": "D017029",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Xiao-Rong Liu",
"url": "https://questionsmedicales.fr/author/Xiao-Rong%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Yong-Hong Yi",
"url": "https://questionsmedicales.fr/author/Yong-Hong%20Yi",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Jie Wang",
"url": "https://questionsmedicales.fr/author/Jie%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Wei-Ping Liao",
"url": "https://questionsmedicales.fr/author/Wei-Ping%20Liao",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Tinea Gladiatorum Detection With a Dermatophyte Test Strip.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36395517",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/JSM.0000000000001097"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tinea of vellus hair: shining under the Wood's lamp.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35706140",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ced.15218"
}
},
{
"@type": "ScholarlyArticle",
"name": "Multidrug resistant tinea corporis/cruris: Response to voriconazole.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35785725",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.mycmed.2022.101306"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tinea capitis caused by Trichophyton tonsurans among adults: Clinical characteristics and treatment response.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36219520",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/myc.13536"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical Features and Skin Microbiome of Tinea Scrotum: An Observational Study of 113 Cases in China.",
"datePublished": "2023-04-18",
"url": "https://questionsmedicales.fr/article/37072674",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11046-023-00712-6"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphalopathies",
"item": "https://questionsmedicales.fr/mesh/D001927"
},
{
"@type": "ListItem",
"position": 5,
"name": "Épilepsie",
"item": "https://questionsmedicales.fr/mesh/D004827"
},
{
"@type": "ListItem",
"position": 6,
"name": "Épilepsies partielles",
"item": "https://questionsmedicales.fr/mesh/D004828"
},
{
"@type": "ListItem",
"position": 7,
"name": "Épilepsie partielle complexe",
"item": "https://questionsmedicales.fr/mesh/D017029"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Épilepsie partielle complexe - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Épilepsie partielle complexe",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Épilepsie partielle complexe",
"description": "Comment diagnostique-t-on l'épilepsie partielle complexe ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nPeut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=1#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Épilepsie partielle complexe",
"description": "Quels sont les symptômes typiques des crises ?\nLes crises peuvent-elles affecter la mémoire ?\nComment se manifestent les comportements automatisés ?\nLes crises peuvent-elles être précédées d'aura ?\nLes symptômes peuvent-ils persister après la crise ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=1#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Épilepsie partielle complexe",
"description": "Peut-on prévenir les crises d'épilepsie partielle complexe ?\nQuels sont les déclencheurs courants des crises ?\nL'éducation des proches est-elle importante ?\nLes activités physiques sont-elles sûres ?\nComment gérer le stress pour prévenir les crises ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=1#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Épilepsie partielle complexe",
"description": "Quels médicaments sont couramment prescrits ?\nLa chirurgie est-elle une option de traitement ?\nQuelles sont les alternatives aux médicaments ?\nComment évaluer l'efficacité du traitement ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=1#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Épilepsie partielle complexe",
"description": "Quelles sont les complications possibles de l'épilepsie ?\nL'épilepsie peut-elle affecter la vie sociale ?\nY a-t-il un risque accru de dépression ?\nLes crises peuvent-elles entraîner des blessures graves ?\nComment les complications peuvent-elles être gérées ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=1#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Épilepsie partielle complexe",
"description": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?\nL'âge influence-t-il le risque d'épilepsie ?\nLes maladies neurologiques augmentent-elles le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=1#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'épilepsie partielle complexe ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical, l'EEG et l'imagerie cérébrale."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'EEG et l'IRM sont essentiels pour visualiser l'activité cérébrale et les anomalies."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent différer selon la localisation de l'activité épileptique."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les antécédents de crises et les facteurs déclenchants."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut se manifester chez les enfants, nécessitant une évaluation spécialisée."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes typiques des crises ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mouvements involontaires, des hallucinations et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles affecter la mémoire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les crises peuvent entraîner des pertes de mémoire temporaires ou des confusions."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les comportements automatisés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements automatisés incluent des gestes répétitifs sans conscience de l'environnement."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles être précédées d'aura ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes ressentent une aura, un signe avant-coureur de la crise."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils persister après la crise ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fatigue ou la confusion peuvent persister après la crise."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les crises d'épilepsie partielle complexe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien qu'il soit difficile de prévenir, éviter les déclencheurs connus peut aider."
}
},
{
"@type": "Question",
"name": "Quels sont les déclencheurs courants des crises ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, le manque de sommeil et l'alcool sont des déclencheurs fréquents."
}
},
{
"@type": "Question",
"name": "L'éducation des proches est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les proches sur les crises et les premiers secours est crucial."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles sûres ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités peuvent être sûres, mais il est important de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour prévenir les crises ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de relaxation comme la méditation peuvent aider à gérer le stress."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont couramment prescrits ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticonvulsivants comme la carbamazépine et la lamotrigine sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée si les médicaments ne contrôlent pas les crises."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives aux médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies comportementales et la stimulation cérébrale peuvent être des options."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la fréquence des crises et les effets secondaires des médicaments."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant sommeil et gestion du stress, peut aider."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'épilepsie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les blessures lors des crises et des problèmes psychologiques."
}
},
{
"@type": "Question",
"name": "L'épilepsie peut-elle affecter la vie sociale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des difficultés sociales et des stigmates associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de dépression ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes épileptiques présentent un risque plus élevé de dépression et d'anxiété."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles entraîner des blessures graves ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chutes ou les accidents pendant une crise peuvent causer des blessures graves."
}
},
{
"@type": "Question",
"name": "Comment les complications peuvent-elles être gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prise en charge multidisciplinaire est essentielle pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les traumatismes crâniens et les infections cérébrales sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'épilepsie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'épilepsie peut survenir à tout âge, mais elle est plus fréquente chez les jeunes enfants et les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les maladies neurologiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérose en plaques peuvent augmenter le risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme l'exposition à des toxines peuvent contribuer au risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut déclencher des crises chez certaines personnes épileptiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/04/2025
Contenu vérifié selon les dernières recommandations médicales
10 publications dans cette catégorie
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Institute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou 510260, China.
Publications dans "Épilepsie partielle complexe" :
5 publications dans cette catégorie
Affiliations :
Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University, Via Montpellier 1, Rome, 00133, Italy.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Affiliated Foshan Maternity and Child Healthcare Hospital, Southern Medical University, Foshan, China.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Neurology and Epileptology, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, Warsaw, 04-730, Poland.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Development and Regeneration-Section Pediatric Neurology, University Hospitals KU Leuven, Leuven, Belgium.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Medical University Vienna, Vienna, Austria.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Necker- Enfants Malades Hospital, University Paris Descartes, Imagine Institute, Paris, France.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Diagnose und Behandlungszentrum für Kinder und Jugendliche, Vivantes Klinikum Neuköln, Berlin, Germany.
Publications dans "Épilepsie partielle complexe" :
4 publications dans cette catégorie
Affiliations :
Department of Neurology and Epileptology, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, Warsaw, 04-730, Poland.
Department of Child Neurology, Medical University of Warsaw, Warsaw, Poland.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, The Ministry of Education of China, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou 510260, China.
Publications dans "Épilepsie partielle complexe" :
3 publications dans cette catégorie
Affiliations :
Department of pediatrics, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Publications dans "Épilepsie partielle complexe" :
Determine sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and concordance of diafactory hs-TP (DTS) to detect tinea gladiatorum using direct potassium hydro...
Prospective, comparative study....
Seventeen Minnesota high schools during the winter wrestling season....
Seventy-one consecutive high school wrestlers identified with a suspicious rash during skin inspection....
Samples were obtained from each rash for both DTS and direct KOH microscopy....
Readings were recorded as positive or negative....
Direct KOH microscopy identified tinea gladiatorum in 35 of the 71 samples (46%). DTS sensitivity was 80% (95% confidence interval 63%-92%), and specificity was 82% (66%-92%). PPV was 85% (68%-95%), a...
Similar to rapid Covid antigen tests, DTS required brief, basic training to perform and gave onsite results in 5 to 30 minutes. Although DTS is not approved for use in the United States by the FDA, co...
We herein reported a simple and cheap method to diagnose the tinea of vellus hair, which is long-neglected and always wrongly treated....
The increasing worldwide resistance to terbinafine and older antifungal drugs, coupled with often erratic clinical responses to itraconazole, leaves dermatologists with limited options to deal with de...
Trichophyton tonsurans tinea capitis has become a growing epidemiological concern. Yet, its clinical manifestations and treatment response, specifically among adults, have only been described among sm...
To assess clinical manifestations and treatment outcome of T. tonsurans tinea capitis among adults....
A retrospective cohort study was carried out among 111 adults with T. tonsurans tinea capitis. Diagnosis was confirmed by fungal culture or polymerase chain reaction. Examinees' demographics, disease ...
The mean age was 20.1 years (±3.1), with men (98.2%) outnumbering women. The follow-up lasted 12.2 months (±5.6). The majority of T. tonsurans tinea capitis was seen in the occipital area (87.6%). In ...
The most common clinical presentation of T. tonsurans tinea capitis included occipital scaly plaques and papules with concomitant non-scalp lesions. Oral terbinafine was found to be highly effective. ...
The scrotum is considered as an uncommon site for tinea, hence there is a lack of knowledge about the clinical characteristics, pathogenic agents and the skin microbiome changes of tinea scrotum....
We sought to analyze the clinical features, pathogenic agents and skin microbiome of tinea scrotum....
A two-center prospective observational study was carried out in outpatient dermatology clinics in Zhejiang, China, from September 2017 to September 2019. The diagnosis of tinea scrotum was confirmed b...
A total of 113 patients with tinea scrotum were included. Tinea scrotum was either presented with isolated lesions (9/113, 8.0%) or accompanied by tinea of other sites (104/113, 92.0%). Tinea cruris w...
Tinea scrotum was often companied by superficial fungal infections of other skin sites, with tinea cruris being the most common condition. Instead of N. gypsea, T. rubrum was the most frequently ident...
Tinea corporis (TC; ringworm or dermatophytosis) is a superficial skin infection caused by...
A double-blind, randomized, placebo-controlled, two parallel arms trial was conducted on 62 individuals suffering from TC at the National Institute of Homoeopathy, India. Participants were randomized ...
The primary outcome revealed no improvement in either of the groups (...
Results were negative on the primary outcome; however, secondary outcomes included some statistically significant results favoring IHMs against placebo after 3 months....
CTRI/2019/11/021999; UTN: U1111-1242-0070....
Dermatophyte infections are widespread worldwide and are the most prevalent cause of fungal infection of the skin, hair, and nails. Tinea corporis is most commonly caused by dermatophytes belonging to...
BACKGROUND Pityriasis rubra pilaris (PRP) is a rare chronic inflammatory skin condition characterized by follicular, papulosquamous, reddish-orange scaling, palmoplantar keratoderma, and erythema with...
For more than 30 years, an 82-year-old man has been suffering from tinea corporis generalisata in the sense of Trichophyton rubrum syndrome. The patient received long-term treatment with terbinafine. ...
Itraconazole follows non-linear pharmacokinetics and hence is recommended once daily, but in real-world practice, is commonly prescribed as twice daily. Hence, this study aimed to evaluate the efficac...
A total of 261 eligible patients were enrolled in this prospective, randomized, clinical study from December-2021 to August-2022 at seven centers in India. Efficacy and safety assessments were done at...
Of 261 patients, 240 were included in the analysis. At week-6, 140 patients were completely cured; thus, overall cure rate was 58.33%. Fifty-five patients (69%) in SB-130 while 47/77 (61%) and 38/83 (...
In this clinical study, moderate efficacy with all doses of ITZ was reported but was better with OD dosing. Although there was no statistical difference between SB-130 and CITZ-200, SB-130 may be pref...